Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
TLR3 agonists and proinflammatory antitumor activities.
Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors.
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors. iScience. 2023 Aug 18; 26(8):107302.
View in:
PubMed
authors with profiles
Ravi Salgia